PANTHERx is delighted to announce that we are a winner of the 2019 Pittsburgh Business Times Best Places to Work Award. Over the past year PANTHERx has experienced tremendous growth and change; opening a third location, reimagining our brand, and introducing new leadership to the team. Through all the restructuring, policy enhancements, and planned growth […]

Click here to read the full press release.   As the medical community has learned more about rare diseases and the complex medications and models used to treat rare disease patients, rare pharmacy has emerged as a growing sub-section of specialty pharmacy with its own unique domain of knowledge and skills. With this in mind, […]

As part of the PANTHERx Specialty Pharmacy Fellowship Program, our 2018-2019 fellows, Olivia Goss, Pharm.D., and Brandon Barry, Pharm.D., conducted research and presented their findings at the 2019 AMCP Conference. As our fellowship year draws to a close, we reflect on the research results of our fellows: About the Research Projects Dr. Goss centered her […]

PANTHERx Specialty Pharmacy, the industry leading independent national specialty pharmacy, has been selected by Paratek Pharmaceuticals, Inc. as a limited pharmacy network provider of its new once-daily oral antibiotic, Nuzyra™ (omadacycline). Nuzyra™ is a tetracycline class antibacterial approved to treat adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). […]

Last week PANTHERx participated in the 2019 Asembia Specialty Pharmacy Summit in Las Vegas, NV, where we met with partners, announced strategic collaborations, unveiled the new PANTHERx brand, and shared insights about the state-of-the-art rare and orphan drugs in the specialty pharmacy industry. We are delighted to have been a part of Asembia for yet […]